Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000178

EVP, Chief Scientific Officer sold 10,000 shares at $43.98 ($439,776)

  • EVP, Chief Scientific Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-18 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $32.60 $326,000 103,466 D
2025-08-18 Sale : show line 2 in the form 10b5-1 −10,000 $43.98 $439,776 93,466 D
Open-market sales · 10,000 sh · avg $43.98 · $439,776

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-18 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −10,000 18,869 D
Loading xslF345X05/edgardoc.xml…